HANCOCK WHITNEY CORP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HANCOCK WHITNEY CORP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$227,000
-3.0%
5,433
-1.5%
0.01%
-11.1%
Q3 2020$234,000
-8.2%
5,515
+3.9%
0.01%
-10.0%
Q2 2020$255,000
-25.4%
5,306
-28.6%
0.01%
-23.1%
Q1 2020$342,000
-52.8%
7,436
-38.3%
0.01%
-43.5%
Q4 2019$724,000
+40.9%
12,056
+32.8%
0.02%
+35.3%
Q3 2019$514,000
-4.6%
9,080
-6.2%
0.02%0.0%
Q2 2019$539,0009,6810.02%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders